Fujifilm Corporation have announced an investment of $1.2 billion to further expand their bio-manufacturing facility in North Carolina, United States.

The facility will incorporate sustainability initiatives that contribute to net-zero operations.

All operational energy needs are anticipated to be completely offset by renewable sources, including landfill gas, onsite solar power, and an annual sustainable solar energy procurement of 125,000 MWh through a virtual power purchase agreement.

Furthermore, the campus is committed to additional sustainability objectives in water and waste reduction, in alignment with Fujifilm’s Sustainable Value Plan 2030.

Progress toward LEED Gold Certification is underway, with initiatives such as diverting 90% of construction waste from landfills, expanding rooftop solar capacity, implementing heat recovery chiller systems for enhanced efficiency, utilizing low embodied carbon concrete with waste fly ash for a 10% decrease in carbon emissions compared to standard cement, and installing ultra-low Nitrogen Oxide boilers to cut nitrogen emissions by 50%.

The facility is aimed to support biopharma customers’ end-to-end needs, and provide supply chain resiliency.

“This investment is an important step to further accelerate the growth of our biopharmaceutical CDMO business,” said Teiichi Goto, president and chief executive officer, representative director, Fujifilm Corporation.

Fujifilm are planning to expand throughout Europe with identical large-scale production facilities to ensure customers can seamlessly integrate production regardless of location.